PRIMARY LOCATIONS
secondary LOCATIONS
beijing
seoul
shanghai
tokyo
hong kong sar
hyderabad
bangalore
singapore
sydney
melbourne
Rating
3.75
3.25
4.25
3.5
4.5
4.0
manufacturing
logistics
research & development
SALES
Most manufacturing facilities are owner-occupied by large firms. Little room for SMEs
Well developed and established infrastructure but limited cold storage for lease
Numerous patents and strong research capability. Limited private R&D rental labs
Presence of international life sciences companies whereas global expansion by leading domestic firms
More than 200 life science manufacturing facilities available and is the largest national production base for COVID-19 vaccines
New policies and ample talent pool to further enhance research capabilities and innovation
Limited supply of high standard and cold storage facilities. Depend on neighboring cities
Presence of both international and leading domestic life sciences companies
sales
hong kong
Limited sites for manufacturing. Transfer most production base to cities in Greater Bay Area
Supportive government policies and tax deductions for qualified R&D expenditure
Limited modern purpose-built facilities specialised for pharmaceutical storage despite cold storage assets available
Positioned as a regional sales office and fund raising centre
Specialise in generic drug production. Shift in production base to other markets due to high labour costs
New policies to boost the development of bio-health industry and medical device development
Double digit growth in pharmaceutical exports and cold storage is gaining taction among local and global logistics companies
International life sciences companies focus on sales offices and close factories in Korea
Dedicated districts to high-end drug manufacturing and animal vaccine production
Presence of medical colleges, advanced research institutes and incubators to facilitate drug development
Boasting advanced infrastructure together with cold storage supply for handling pharmaceuticals products
Continuous increase in global and domestic medicines sales and presence sales office of most global giants
Singapore
Relevant and specialised infrastructure to allow efficient operation of manufacturing
Supportive government policies, presence of life sciences parks and healthy talent pools to encourage R&D growth
A major exporter of pharmaceutical goods and has the highest number of certified companies able to handle pharmaceutical products in the region
Positioned as a regional headquarters for global life sciences giants
BANGALORE
Well known for producing high-quality medicines at a relatively low average cost. 40% of pharmaceutical products are exported globally
Home to around 60% of all major biotech firms in India and hosts more than 35 clinical research organizations and key institutions
Presence of an international airport and a well-established intra and inter-state road network
Preferred location for the India headquarters of various global and domestic life science companies
Hyderabad
Account for about one-third of India’s pharmaceutical production and global vaccine production
The Genome Valley is the largest and most vibrant R&D cluster in India. Sufficient talent pool available
Presence of first airport-based dedicated pharmaceutical zone with temperature-controlled life science cargo storage and handling facilities
Host offices of over 2500 pharmaceutical companies
Melbourne
Global reputation for the innovative and advanced manufacturing of pharmaceutical and medical technology products
A leading global biotechnology hub and home to two of the world’s top universities for biomedical research
Extensive infrastructure and presence of efficient and specialised third party logistics providers
Positioned as a gateway market in Asia Pacific and also home of half of all ASX-listed life science companies
Numerous quality existing facilities to manufacture drugs and vaccines locally
New South Wales (NSW) is home to the largest Biobank in the southern hemisphere
Hosts 30% of the country’s home grown biotech companies and presence of global companies
